Anixa Biosciences Inc (ANIX) stock
ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
$2.62−0.06 (-2.24%)
Close on Nov 13, 2026Market cap $91.08MP/E –Yield –
Anixa Biosciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Anixa Biosciences's ebitda for the twelve months ending Apr 30, 2019 was -$18.56M. For fiscal 2018 it was -$14.27M. The highest annual figure on record is -$932.24K in fiscal 2015.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Oct 31, 2018 | -$14.27M | – |
| FY2017 | Oct 31, 2017 | -$6.03M | – |
| FY2016 | Oct 31, 2016 | -$4.48M | – |
| FY2015 | Oct 31, 2015 | -$932.24K | – |
| FY2012 | Oct 31, 2012 | -$4.13M | – |
| FY2011 | Oct 31, 2011 | -$5.02M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | -$2.58M | – |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | -$4.98M | – |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | -$5.40M | – |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | -$5.60M | – |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | -$1.40M | – |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | -$1.87M | – |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | -$1.73M | – |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | -$1.72M | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | -$1.20M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | -$1.38M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | -$904.88K | – |
See a number that looks wrong?